{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:01:22Z","timestamp":1785128482784,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"France 2030 Plan \u201cProjets d\u2019Innovation\u201d","award":["DOS0222542\/00"],"award-info":[{"award-number":["DOS0222542\/00"]}]},{"name":"France 2030 Plan \u201cProjets d\u2019Innovation\u201d","award":["DOS0222543\/00"],"award-info":[{"award-number":["DOS0222543\/00"]}]},{"name":"Programme d\u2019investissements d\u2019avenir","award":["BFTE DOS0178148\/00"],"award-info":[{"award-number":["BFTE DOS0178148\/00"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00204-024-03833-z","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T11:02:56Z","timestamp":1722942176000},"page":"3875-3884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models"],"prefix":"10.1007","volume":"98","author":[{"given":"Salom\u00e9","family":"Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cherradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3628-0405","authenticated-orcid":false,"given":"Hong Tuan","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"issue":"8","key":"3833_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/10937404.2023.2261848","volume":"26","author":"R Allison","year":"2023","unstructured":"Allison R, Guraka A, Shawa IT, Tripathi G, Moritz W, Kermanizadeh A (2023) Drug induced liver injury - a 2023 update. J Toxicol Environ Health B Crit Rev 26(8):442\u2013467. https:\/\/doi.org\/10.1080\/10937404.2023.2261848","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"9","key":"3833_CR2","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.cell.2024.03.036","volume":"187","author":"S Carpenter","year":"2024","unstructured":"Carpenter S, O\u2019Neill LAJ (2024) From periphery to center stage: 50 years of advancements in innate immunity. Cell 187(9):2030\u20132051. https:\/\/doi.org\/10.1016\/j.cell.2024.03.036","journal-title":"Cell"},{"key":"3833_CR3","doi-asserted-by":"publisher","first-page":"1166214","DOI":"10.3389\/fimmu.2023.1166214","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen S, Liao Z, Xu P (2023) Mitochondrial control of innate immune responses. Front Immunol 14:1166214. https:\/\/doi.org\/10.3389\/fimmu.2023.1166214","journal-title":"Front Immunol"},{"issue":"10","key":"3833_CR4","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/liv.14940","volume":"41","author":"D Cheng","year":"2021","unstructured":"Cheng D, Chai J, Wang H, Fu L, Peng S, Ni X (2021) Hepatic macrophages: Key players in the development and progression of liver fibrosis. Liver Int 41(10):2279\u20132294. https:\/\/doi.org\/10.1111\/liv.14940","journal-title":"Liver Int"},{"issue":"6","key":"3833_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s44164-023-00057-w10.1007\/s44164-023-00057-w","volume":"2","author":"S Cherradi","year":"2023","unstructured":"Cherradi S, Taulet N, Duong HT (2023) An original donor-dependent spheroid system for the prediction of idiosyncratic drug-induced liver injury risk. In Vitro Models 2(6):281\u2013295. https:\/\/doi.org\/10.1007\/s44164-023-00057-w10.1007\/s44164-023-00057-w","journal-title":"In Vitro Models"},{"issue":"2","key":"3833_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/hep.20567","volume":"41","author":"M Chojkier","year":"2005","unstructured":"Chojkier M (2005) Troglitazone and liver injury: in search of answers. Hepatology 41(2):237\u2013246. https:\/\/doi.org\/10.1002\/hep.20567","journal-title":"Hepatology"},{"key":"3833_CR7","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","volume":"9","author":"S Fiorucci","year":"2018","unstructured":"Fiorucci S, Biagioli M, Zampella A, Distrutti E (2018) Bile acids activated receptors regulate innate immunity. Front Immunol 9:1853","journal-title":"Front Immunol"},{"issue":"8","key":"3833_CR8","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.cgh.2022.12.040","volume":"21","author":"RJ Fontana","year":"2023","unstructured":"Fontana RJ, Bjornsson ES, Reddy R, Andrade RJ (2023) The evolving profile of idiosyncratic drug-induced liver injury. Clin Gastroenterol Hepatol 21(8):2088\u20132099. https:\/\/doi.org\/10.1016\/j.cgh.2022.12.040","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"3833_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1124\/mol.59.3.627","volume":"59","author":"C Funk","year":"2001","unstructured":"Funk C, Ponelle C, Scheuermann G, Pantze M (2001) Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat. Mol Pharmacol 59(3):627\u2013635","journal-title":"Mol Pharmacol"},{"issue":"7","key":"3833_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s002040100251","volume":"75","author":"JR Haskins","year":"2001","unstructured":"Haskins JR, Rowse P, Rahbari R, de la Iglesia FA (2001) Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes. Arch Toxicol 75(7):425\u2013438. https:\/\/doi.org\/10.1007\/s002040100251","journal-title":"Arch Toxicol"},{"issue":"2","key":"3833_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112141","volume":"42","author":"AD Hildreth","year":"2023","unstructured":"Hildreth AD, Padilla ET, Tafti RY, Legala AR, O\u2019Sullivan TE (2023) Sterile liver injury induces a protective tissue-resident cDC1-ILC1 circuit through cDC1-intrinsic cGAS-STING-dependent IL-12 production. Cell Rep 42(2):112141. https:\/\/doi.org\/10.1016\/j.celrep.2023.112141","journal-title":"Cell Rep"},{"issue":"6","key":"3833_CR12","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.3390\/ijms22062954","volume":"22","author":"A Jee","year":"2021","unstructured":"Jee A, Sernoskie SC, Uetrecht J (2021) Idiosyncratic drug-induced liver injury: mechanistic and clinical challenges. Int J Mol Sci 22(6):2954. https:\/\/doi.org\/10.3390\/ijms22062954","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3833_CR13","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1124\/dmd.118.082719","volume":"46","author":"JG Kenna","year":"2018","unstructured":"Kenna JG, Uetrecht J (2018) Do in vitro assays predict drug candidate idiosyncratic drug-induced liver injury risk? Drug Metab Dispos 46(11):1658\u20131669. https:\/\/doi.org\/10.1124\/dmd.118.082719","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3833_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s40828-022-00163-4","volume":"8","author":"U Lendeckel","year":"2022","unstructured":"Lendeckel U, Venz S, Wolke C (2022) Macrophages: shapes and functions. ChemTexts 8(2):12. https:\/\/doi.org\/10.1007\/s40828-022-00163-4","journal-title":"ChemTexts"},{"issue":"1","key":"3833_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/1547691X.2018.1516014","volume":"16","author":"A Mak","year":"2019","unstructured":"Mak A, Uetrecht J (2019) Involvement of CCL2\/CCR2 macrophage recruitment in amodiaquine-induced liver injury. J Immunotoxicol 16(1):28\u201333. https:\/\/doi.org\/10.1080\/1547691X.2018.1516014","journal-title":"J Immunotoxicol"},{"key":"3833_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641240","volume":"12","author":"N Mendez-Sanchez","year":"2021","unstructured":"Mendez-Sanchez N, Cordova-Gallardo J, Barranco-Fragoso B, Eslam M (2021) Hepatic dendritic cells in the development and progression of metabolic steatohepatitis. Front Immunol 12:641240. https:\/\/doi.org\/10.3389\/fimmu.2021.641240","journal-title":"Front Immunol"},{"key":"3833_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2021.105134","volume":"73","author":"F Padberg","year":"2021","unstructured":"Padberg F, Hoper T, Henkel S, Driesch D, Luch A, Zellmer S (2021) Novel indirect co-culture of immortalised hepatocytes with monocyte derived macrophages is characterised by pro-inflammatory cytokine networks. Toxicol in Vitro 73:105134. https:\/\/doi.org\/10.1016\/j.tiv.2021.105134","journal-title":"Toxicol in Vitro"},{"key":"3833_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156347","volume":"170","author":"P Pratim Das","year":"2023","unstructured":"Pratim Das P, Medhi S (2023) Role of inflammasomes and cytokines in immune dysfunction of liver cirrhosis. Cytokine 170:156347. https:\/\/doi.org\/10.1016\/j.cyto.2023.156347","journal-title":"Cytokine"},{"issue":"12","key":"3833_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082562","volume":"8","author":"SC Preissner","year":"2013","unstructured":"Preissner SC, Hoffmann MF, Preissner R, Dunkel M, Gewiess A, Preissner S (2013) Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy. PLoS ONE 8(12):e82562. https:\/\/doi.org\/10.1371\/journal.pone.0082562","journal-title":"PLoS ONE"},{"key":"3833_CR20","doi-asserted-by":"publisher","first-page":"1378371","DOI":"10.3389\/fphar.2024.1378371","volume":"15","author":"S Roux","year":"2024","unstructured":"Roux S, Cherradi S, Duong HT (2024) Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone. Front Pharmacol 15:1378371. https:\/\/doi.org\/10.3389\/fphar.2024.1378371","journal-title":"Front Pharmacol"},{"issue":"12","key":"3833_CR21","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1016\/j.apsb.2021.11.013","volume":"11","author":"A Segovia-Zafra","year":"2021","unstructured":"Segovia-Zafra A, Di Zeo-Sanchez DE, Lopez-Gomez C et al (2021) Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharm Sin B 11(12):3685\u20133726. https:\/\/doi.org\/10.1016\/j.apsb.2021.11.013","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3833_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/toxsci\/69.1.131","volume":"69","author":"MA Tirmenstein","year":"2002","unstructured":"Tirmenstein MA, Hu CX, Gales TL et al (2002) Effects of troglitazone on HepG2 viability and mitochondrial function. Toxicol Sci 69(1):131\u2013138. https:\/\/doi.org\/10.1093\/toxsci\/69.1.131","journal-title":"Toxicol Sci"},{"key":"3833_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.apha.2018.12.001","volume":"85","author":"J Uetrecht","year":"2019","unstructured":"Uetrecht J (2019) Mechanisms of idiosyncratic drug-induced liver injury. Adv Pharmacol 85:133\u2013163. https:\/\/doi.org\/10.1016\/bs.apha.2018.12.001","journal-title":"Adv Pharmacol"},{"key":"3833_CR24","unstructured":"Vanden Heuvel JPM, S.; Granda, M. V.; Shef, B. Examination Of Drug-induced Liver Injury In upcyte Hepatocytes. In: Society of Toxicology (SOT), San Antonio, Texas, 2018."},{"key":"3833_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-0716-2938-3_11","volume":"2618","author":"J Villar","year":"2023","unstructured":"Villar J, Coillard A, van Roessel C, Segura E (2023) Culture system allowing the simultaneous differentiation of human monocytes into dendritic cells and macrophages using M-CSF, IL-4, and TNF-alpha. Methods Mol Biol 2618:147\u2013154. https:\/\/doi.org\/10.1007\/978-1-0716-2938-3_11","journal-title":"Methods Mol Biol"},{"issue":"3","key":"3833_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbrc.2017.03.106","volume":"486","author":"D Wang","year":"2017","unstructured":"Wang D, Shi L, Xin W et al (2017) Activation of PPARgamma inhibits pro-inflammatory cytokines production by upregulation of miR-124 in vitro and in vivo. Biochem Biophys Res Commun 486(3):726\u2013731. https:\/\/doi.org\/10.1016\/j.bbrc.2017.03.106","journal-title":"Biochem Biophys Res Commun"},{"key":"3833_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103213","volume":"64","author":"HH Wang","year":"2021","unstructured":"Wang HH, Huang JH, Sue MH et al (2021) Interleukin-24 protects against liver injury in mouse models. EBioMedicine 64:103213. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103213","journal-title":"EBioMedicine"},{"issue":"6","key":"3833_CR28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/hep4.1064","volume":"1","author":"YI Yamashita","year":"2017","unstructured":"Yamashita YI, Imai K, Mima K et al (2017) Idiosyncratic drug-induced liver injury: a short review. Hepatol Commun 1(6):494\u2013500. https:\/\/doi.org\/10.1002\/hep4.1064","journal-title":"Hepatol Commun"},{"key":"3833_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/961753","volume":"2008","author":"XY Yang","year":"2008","unstructured":"Yang XY, Wang LH, Farrar WL (2008) A role for PPARgamma in the regulation of cytokines in immune cells and cancer. PPAR Res 2008:961753. https:\/\/doi.org\/10.1155\/2008\/961753","journal-title":"PPAR Res"},{"issue":"23","key":"3833_CR30","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms222312808","volume":"22","author":"M Zhao","year":"2021","unstructured":"Zhao M, Ma J, Li M et al (2021) Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci 22(23):12808. https:\/\/doi.org\/10.3390\/ijms222312808","journal-title":"Int J Mol Sci"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03833-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-024-03833-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03833-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T10:03:10Z","timestamp":1729245790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-024-03833-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3833"],"URL":"https:\/\/doi.org\/10.1007\/s00204-024-03833-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.C., S.R., and H.T.D. are employees of PredictCan Biotechnologies SAS. S.C. and H.T.D. are founders of PredictCan Biotechnologies SAS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}